Zhand Sareh, Tabarraei Alijan, Nazari Amineh, Moradi Abdolvahab
Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Tehran University of Medical Sciences, Tehran, Iran.
Indian J Gastroenterol. 2017 Jul;36(4):253-257. doi: 10.1007/s12664-017-0767-z. Epub 2017 Jul 25.
Hepatitis B virus (HBV) is vulnerable to many various mutations. Those within epitopes recognized by sensitized T cells may influence the re-emergence of the virus. This study was designed to investigate the mutation in immune epitope regions of HBV pre-core/core among chronic HBV patients of Golestan province, Northeast Iran.
In 120 chronic HBV carriers, HBV DNA was extracted from blood plasma samples and PCR was done using specific primers. Direct sequencing and alignment of the pre-core/core region were applied using reference sequence from Gene Bank database (Accession Number AB033559).
The study showed 27 inferred amino acid substitutions, 9 of which (33.3%) were in CD4 and 2 (7.4%) in cytotoxic T lymphocytes' (CTL) epitopes and 16 other mutations (59.2%) were observed in other regions.
CTL escape mutations were not commonly observed in pre-core/core sequences of chronic HBV carriers in the locale of study. It can be concluded that most of the inferred amino acid substitutions occur in different immune epitopes other than CTL and CD4.
乙型肝炎病毒(HBV)易发生多种突变。致敏T细胞识别的表位内的突变可能影响病毒的再次出现。本研究旨在调查伊朗东北部戈勒斯坦省慢性HBV患者中HBV前核心/核心免疫表位区域的突变情况。
在120例慢性HBV携带者中,从血浆样本中提取HBV DNA,并使用特异性引物进行PCR。利用基因库数据库(登录号AB033559)的参考序列对前核心/核心区域进行直接测序和比对。
该研究显示有27个推断的氨基酸替换,其中9个(33.3%)位于CD4表位,2个(7.4%)位于细胞毒性T淋巴细胞(CTL)表位,其他区域观察到16个其他突变(59.2%)。
在研究地区的慢性HBV携带者的前核心/核心序列中,未普遍观察到CTL逃逸突变。可以得出结论,大多数推断的氨基酸替换发生在CTL和CD4以外的不同免疫表位中。